These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37566530)

  • 21. Telehealth in school-based practice: Perceived viability to bridge global OT practitioner shortages prior to COVID-19 global health emergency.
    Abbott-Gaffney C; Jacobs K
    Work; 2020; 67(1):29-35. PubMed ID: 32925151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early experiences of nusinersen for the treatment of spinal muscular atrophy: Results from a large survey of patients and caregivers.
    Chen E; Dixon S; Naik R; Noone JM; Buchenberger JD; Whitmire SM; Mills R; Arnold W
    Muscle Nerve; 2021 Mar; 63(3):311-319. PubMed ID: 33184859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians.
    Sloan M; Lever E; Harwood R; Gordon C; Wincup C; Blane M; Brimicombe J; Lanyon P; Howard P; Sutton S; D'Cruz D; Naughton F
    Rheumatology (Oxford); 2022 May; 61(6):2262-2274. PubMed ID: 34698822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A National Spinal Muscular Atrophy Registry for Real-World Evidence.
    Hodgkinson VL; Oskoui M; Lounsberry J; M'Dahoma S; Butler E; Campbell C; MacKenzie A; McMillan HJ; Simard L; Vajsar J; Brais B; Chapman KM; Chrestian N; Crone M; Dobrowolski P; Dojeiji S; Dowling JJ; Dupré N; Genge A; Gonorazky H; Hasal S; Izenberg A; Johnston W; Leung E; Lochmüller H; Mah JK; Marerro A; Massie R; McAdam L; McCormick A; Melanson M; Mezei MM; Nguyen CE; O'Connell C; O'Ferrall EK; Pfeffer G; Phan C; Plamondon S; Poulin C; Rodrigue X; Schellenberg KL; Selby K; Sheriko J; Shoesmith C; Smith G; Taillon M; Taylor S; Warman Chardon J; Worley S; Korngut L
    Can J Neurol Sci; 2020 Nov; 47(6):810-815. PubMed ID: 32493524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding European patient expectations towards current therapeutic development in spinal muscular atrophy.
    Gusset N; Stalens C; Stumpe E; Klouvi L; Mejat A; Ouillade MC; de Lemus M
    Neuromuscul Disord; 2021 May; 31(5):419-430. PubMed ID: 33752935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Burden of Spinal Muscular Atrophy on Informal Caregivers.
    Aranda-Reneo I; Peña-Longobardo LM; Oliva-Moreno J; Litzkendorf S; Durand-Zaleski I; Tizzano EF; López-Bastida J
    Int J Environ Res Public Health; 2020 Dec; 17(23):. PubMed ID: 33276656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring patient perspectives on telemedicine monitoring within the operating room.
    Abraham J; Meng A; Holzer KJ; Brawer L; Casarella A; Avidan M; Politi MC
    Int J Med Inform; 2021 Dec; 156():104595. PubMed ID: 34627112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How do orphan disease patients live during the pandemic of Omicron variant? A nationwide survey of spinal muscular atrophy patients in China.
    Jiao Y; Zhao J; Wang Z; Chen X; Cai H; Huang X; Sun P; Shen J; Song F; Xiong H; Dai Y; Chen W; Shen J
    Int J Infect Dis; 2023 Sep; 134():187-194. PubMed ID: 37352912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study.
    Kiefer P; Kirschner J; Pechmann A; Langer T
    Orphanet J Rare Dis; 2020 Jul; 15(1):194. PubMed ID: 32727502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient and Caregiver Outcomes After Onasemnogene Abeparvovec Treatment: Findings from the Cure SMA 2021 Membership Survey.
    Toro W; Yang M; Georgieva M; Anderson A; LaMarca N; Patel A; Akbarnejad H; Dabbous O
    Adv Ther; 2023 Dec; 40(12):5315-5337. PubMed ID: 37776479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community Insights.
    Curry M; Peterson I; Belter L; Sarr F; Whitmire S; Schroth M; Jarecki J
    Neurol Ther; 2023 Oct; 12(5):1631-1647. PubMed ID: 37347432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives.
    Farrar MA; Carey KA; Paguinto SG; Chambers G; Kasparian NA
    BMJ Open; 2018 May; 8(5):e020907. PubMed ID: 29794098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating Perceived Fatigue within an Adult Spinal Muscular Atrophy Population.
    Belter L; Peterson I; Jarecki J
    Neurol Ther; 2023 Dec; 12(6):2161-2175. PubMed ID: 37856000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding caregiver experiences with disease-modifying therapies for spinal muscular atrophy: a qualitative study.
    Xiao L; Kang S; Djordjevic D; Gonorazky H; Chiang J; Ambreen M; Nigro E; Law E; Weinstock L; McCradden M; Amin R
    Arch Dis Child; 2023 Nov; 108(11):929-934. PubMed ID: 37419673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing perspectives of disease burden and clinically meaningful changes using the Spinal Muscular Atrophy Health Index in adolescents and young adults.
    Mazzella A; Cruz R; Belter L; Curry M; Dilek N; Zizzi C; Heatwole C; Jarecki J
    Muscle Nerve; 2022 Sep; 66(3):276-281. PubMed ID: 35616549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
    Gauthier-Loiselle M; Cloutier M; Toro W; Patel A; Shi S; Davidson M; Bischof M; LaMarca N; Dabbous O
    Adv Ther; 2021 Dec; 38(12):5809-5828. PubMed ID: 34713391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving Care and Empowering Adults Living with SMA: A Call to Action in the New Treatment Era.
    Walter MC; Chiriboga C; Duong T; Goemans N; Mayhew A; Ouillade L; Oskoui M; Quinlivan R; Vázquez-Costa JF; Vissing J; Servais L
    J Neuromuscul Dis; 2021; 8(4):543-551. PubMed ID: 33646175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survey of Vitreoretinal Specialists in the United States Regarding Telemedicine During the COVID-19 Pandemic.
    Cohen MN; Ammar MJ; Mahmoudzadeh R; Salabati M; Gruver RS; Starr MR; Patel LG; Klufas MA; Garg SJ; Yonekawa Y; Kuriyan AE; Khan MA
    Telemed J E Health; 2022 Dec; 28(12):1817-1822. PubMed ID: 35613374
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of the Assessment of Caregiver Experience with Neuromuscular Disease (ACEND) in Spinal Muscular Atrophy.
    Brown L; Hoffman K; Corbo-Galli C; Dong S; Zumpf K; Weigel C; Blomgren C; Munson H; Bidwell J; Rao V; Kuntz NL; Schwaede A; Krosschell KJ
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398235
    [No Abstract]   [Full Text] [Related]  

  • 40. Reflecting on Plastic Surgery Training During Early COVID-19 Pandemic: Resident Exposure and Telemedicine.
    Epstein A; Jabori SK; Wo LM; Huberman M; Samaha G; Ovadia S; Thaller SR
    J Craniofac Surg; 2022 Sep; 33(6):1820-1824. PubMed ID: 35762598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.